ClinicalTrials.Veeva

Menu

Evaluation of HbA1c Levels and Ovarian Reserve and Type 1 Diabetes

K

Kanuni Sultan Suleyman Training and Research Hospital

Status

Completed

Conditions

Diabetes
Ovarian Failure

Treatments

Diagnostic Test: ovarian reserve

Study type

Observational

Funder types

Other

Identifiers

NCT03907618
2018.10.22

Details and patient eligibility

About

The human ovary is the target of an autoimmune attack, usually in organ or non-specific autoimmune disorders. Serum anti-Müllerian hormone (AMH) levels decrease early in menopause and menopause is seen in women with type 1 diabetes mellitus (DM1) at a young age. DM1 is aimed to show DM1 relationship with ovarian reserve based on the assumption that it will have lower AMH levels than controls, secondary to bad glycemic control and autoimmune attack in women.

Full description

The study was designed prospectively. Ovarian functions in healthy volunteer women and patients who use DM1 diagnosed between 18-40 years old will be examined. Gonadotropin and AMH levels will be measured in follicular phase. To calculate the number of antral follicles (AFC) and ovarian volume, ultrasound will be looked at. Fasting and satiety blood glucose, HbA1c and C-peptide levels will be evaluated.

Enrollment

104 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • female patients between 18 and 40 years of age who had consent and had gynecological examination in our polyclinic;
  • study group for patients with type 1 diabetes mellitus healthy volunteers control group

Exclusion criteria

  • Other endocrine and / or autoimmune disorders, polycystic ovary syndrome (PCOS) and
  • previous surgery, which may reduce ovarian reserves;
  • medical and / or radiotherapy

Trial design

104 participants in 2 patient groups

Group 1 diagnosed with Diabetes Mellitus
Description:
Patients with Type 1 Diabetes Mellitus aged 18-40 years who had ovarian reserve with gynecological examination
Treatment:
Diagnostic Test: ovarian reserve
group 2 control group
Description:
Healthy volunteer patients aged 18-40 years who have no diagnosis of Type 1 Diabetes Mellitus and whose ovarian reserve is evaluated by gynecological examination
Treatment:
Diagnostic Test: ovarian reserve

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems